The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement
Open accessAbstract
Opioid action was thought to exert reinforcing effects solely via the initial agonism of opioid receptors. Here, we present evidence for an additional novel contributor to opioid reward: the innate immune pattern-recognition receptor, toll-like receptor 4 (TLR4), and its MyD88-dependent signaling. Blockade of TLR4/MD2 by administration of the nonopioid, unnatural isomer of naloxone, (+)-naloxone (rats), or two independent genetic knock-outs of MyD88-TLR4-dependent signaling (mice), suppressed opioid-induced conditioned place preference. (+)-Naloxone also reduced opioid (remifentanil) self-administration (rats), another commonly used behavioral measure of drug reward. Moreover, pharmacological blockade of morphine-TLR4/MD2 activity potently reduced morphine-induced elevations of extracellular dopamine in rat nucleus accumbens, a region critical for opioid reinforcement. Importantly, opioid-TLR4 actions are not a unidirectional influence on opioid pharmacodynamics, since TLR4−/−mice had reduced oxycodone-induced p38 and JNK phosphorylation, while displaying potentiated analgesia. Similar to our recent reports of morphine-TLR4/MD2 binding, here we provide a combination of in silico and biophysical data to support (+)-naloxone and remifentanil binding to TLR4/MD2. Collectively, these data indicate that the actions of opioids at classical opioid receptors, together with their newly identified TLR4/MD2 actions, affect the mesolimbic dopamine system that amplifies opioid-induced elevations in extracellular dopamine levels, therefore possibly explaining altered opioid reward behaviors. Thus, the discovery of TLR4/MD2 recognition of opioids as foreign xenobiotic substances adds to the existing hypothesized neuronal reinforcement mechanisms, identifies a new drug target in TLR4/MD2 for the treatment of addictions, and provides further evidence supporting a role for central proinflammatory immune signaling in drug reward.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
Principles of Fluorescence Spectroscopy
Lakowicz, J. R. (1999) · Springer eBooks · doi:10.1007/978-1-4757-3061-6 · Cited by 26,947
Principles of Fluorescence Spectroscopy
(2006) · Springer eBooks · doi:10.1007/978-0-387-46312-4 · Cited by 19,339
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
AChE-stained horizontal sections of the rat brain in stereotaxic coordinates
Paxinos, G., Watson, C. R. R., & Emson, P. C. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90021-7 · Cited by 4,497
The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
Park, B. S., Song, D. H., Kim, H. M., Choi, B.-S., Lee, H., & Lee, J.-O. (2009) · Nature · doi:10.1038/nature07830 · Cited by 2,428
Immune modulation of learning, memory, neural plasticity and neurogenesis
Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483
Ikemoto, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.004 · Cited by 1,477
Broad Expression of Toll-Like Receptors in the Human Central Nervous System
Bsibsi, M., Ravid, R., Gveric, D., & van Noort, J. M. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.11.1013 · Cited by 999
Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α
Stellwagen, D., Beattie, E. C., Seo, J. Y., & Malenka, R. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4486-04.2005 · Cited by 985 · cited 2×
“…by their neuroexcitatory effects (Watkins et al., 2009) of glutamate transporter downregulation (Wang et al., 2003), GABA receptor downregulation (Stellwagen et al., 2005), upregulation of AMPA/NMDA expression and function (De et al., 2003), and enhancement of neurotransmitter release (Youn et…”
BackgroundFujihara, M., Muroi, M., Tanamoto, K.-I., Suzuki, T., Azuma, H., & Ikeda, H. (2003) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.08.003 · Cited by 574
Evidence that opioids may have toll-like receptor 4 and MD-2 effects
Hutchinson, M. R., Zhang, Y., Shridhar, M., Evans, J. H., Buchanan, M. M., Zhao, T. X., Slivka, P. F., Coats, B. D., Rezvani, N., Wieseler, J., et al. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.08.004 · Cited by 573
Self-citationMorphine activates neuroinflammation in a manner parallel to endotoxin
Wang, X., Loram, L. C., Ramos, K., de Jesus, A. J., Thomas, J., Cheng, K., Reddy, A., Somogyi, A. A., Hutchinson, M. R., Watkins, L. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200130109 · Cited by 517
Self-citationIncreased MCP-1 and microglia in various regions of the human alcoholic brain
He, J., & Crews, F. T. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.017 · Cited by 513
Toll-like receptor signaling in neural plasticity and disease
Okun, E., Griffioen, K. J., & Mattson, M. P. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.02.005 · Cited by 510
Watkins, L. R., Hutchinson, M. R., Rice, K. C., & Maier, S. F. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.002 · Cited by 438 · cited 2×
“Such conclusions are supported by their neuroexcitatory effects (Watkins et al., 2009) of glutamate transporter downregulation (Wang et al.”
BackgroundSelf-citationGoldstein, A., Lowney, L. I., & Pal, B. K. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.8.1742 · Cited by 419
Hutchinson, M. R., Shavit, Y., Grace, P. M., Rice, K. C., Maier, S. F., & Watkins, L. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.004135 · Cited by 397
Self-citationAbuse of prescription drugs and the risk of addiction
Compton, W. M., & Volkow, N. D. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.10.020 · Cited by 363
Toll‐like receptor 4 in CNS pathologies
Buchanan, M. M., Hutchinson, M., Watkins, L. R., & Yin, H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06736.x · Cited by 336
Self-citationLPS Sensitizes TRPV1 via Activation of TLR4 in Trigeminal Sensory Neurons
Diogenes, A., Ferraz, C. C. R., Akopian, A. N., Henry, M. A., & Hargreaves, K. M. (2011) · Journal of Dental Research · doi:10.1177/0022034511400225 · Cited by 335
Thomas, D. M., Walker, P. D., Benjamins, J. A., Geddes, T. J., & Kuhn, D. M. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070961 · Cited by 315
Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia
Hutchinson, M. R., Coats, B. D., Lewis, S. S., Zhang, Y., Sprunger, D. B., Rezvani, N., Baker, E. M., Jekich, B. M., Wieseler, J. L., Somogyi, A. A., et al. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.05.004 · Cited by 306
Self-citationHutchinson, M. R., Lewis, S. S., Coats, B. D., Skyba, D. A., Crysdale, N. Y., Berkelhammer, D. L., Brzeski, A., Northcutt, A., Vietz, C. M., Judd, C. M., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.09.012 · Cited by 303
Self-citationNarita, M., Miyatake, M., Narita, M., Shibasaki, M., Shindo, K., Nakamura, A., Kuzumaki, N., Nagumo, Y., & Suzuki, T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301007 · Cited by 218
Wang, Z., Pekarskaya, O., Bencheikh, M., Chao, W., Gelbard, H. A., Ghorpade, A., Rothstein, J. D., & Volsky, D. J. (2003) · Virology · doi:10.1016/s0042-6822(03)00181-8 · Cited by 211
Schwarz, J. M., Hutchinson, M. R., & Bilbo, S. D. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3297-11.2011 · Cited by 203
Self-citationMicroglial activation is a pharmacologically specific marker for the neurotoxic amphetamines
Thomas, D. M., Dowgiert, J., Geddes, T. J., Francescutti-Verbeem, D., Liu, X., & Kuhn, D. M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.065 · Cited by 193
Ventral Tegmental Area BDNF Induces an Opiate-Dependent–Like Reward State in Naïve Rats
Vargas-Perez, H., Ting-A-Kee, R., Walton, C. H., Hansen, D. M., Razavi, R., Clarke, L., Bufalino, M. R., Allison, D. W., Steffensen, S. C., & van der Kooy, D. (2009) · Science · doi:10.1126/science.1168501 · Cited by 187
Coller, J. K., & Hutchinson, M. R. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.008 · Cited by 186
Self-citationLewis, S. S., Hutchinson, M. R., Rezvani, N., Loram, L. C., Zhang, Y., Maier, S. F., Rice, K. C., & Watkins, L. R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.011 · Cited by 184
Self-citationHutchinson, M. R., Northcutt, A. L., Chao, L. W., Kearney, J. J., Zhang, Y., Berkelhammer, D. L., Loram, L. C., Rozeske, R. R., Bland, S. T., Maier, S. F., et al. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.008 · Cited by 180
Self-citationMethadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine
Doverty, M., Somogyi, A. A., White, J. M., Bochner, F., Beare, C. H., Menelaou, A., & Ling, W. (2001) · Pain · doi:10.1016/s0304-3959(01)00306-2 · Cited by 170
Self-citationManchikanti, L. (2006) · PubMed · Cited by 165
The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release
Bland, S. T., Hutchinson, M. R., Maier, S. F., Watkins, L. R., & Johnson, K. W. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.01.014 · Cited by 155
Self-citationMinocycline reduces ethanol drinking
Agrawal, R. G., Hewetson, A., George, C. M., Syapin, P. J., & Bergeson, S. E. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.002 · Cited by 148
Holm, T. H., Dræby, D., & Owens, T. (2012) · Glia · doi:10.1002/glia.22296 · Cited by 134
Lewis, S. S., Loram, L. C., Hutchinson, M. R., Li, C., Zhang, Y., Maier, S. F., Huang, Y., Rice, K. C., & Watkins, L. R. (2012) · Journal of Pain · doi:10.1016/j.jpain.2012.02.005 · Cited by 119
Self-citationHutchinson, M. R., Loram, L. C., Zhang, Y., Shridhar, M., Rezvani, N., Berkelhammer, D. L., Phipps, S., Foster, P. S., Landgraf, K., Falke, J. J., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.03.067 · Cited by 110
Self-citationMilligan, E. D., Hinde, J. L., Mehmert, K. K., Maier, S. F., & Watkins, L. R. (1999) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(99)00075-8 · Cited by 109
Self-citationLaviolette, S. R., Nader, K., & van der Kooy, D. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00327-8 · Cited by 106
Forebrain astroglial plasticity is induced following withdrawal from repeated cocaine administration
Bowers, M. S., & Kalivas, P. W. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02537.x · Cited by 104
Beardsley, P. M., Shelton, K. L., Hendrick, E., & Johnson, K. W. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.010 · Cited by 97
Toll-Like Receptor 9 Is Required for Opioid-Induced Microglia Apoptosis
He, L., Li, H., Chen, L., Miao, J., Jiang, Y., Zhang, Y., Xiao, Z., Hanley, G., Li, Y., Zhang, X., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018190 · Cited by 97
Essential role of toll-like receptor 2 in morphine-induced microglia activation in mice
Zhang, Y., Li, H., Li, Y., Sun, X., Zhu, M., Hanley, G., LeSage, G., & Yin, D. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.11.063 · Cited by 84
Zhang, X., Cui, Y., Cui, Y., Chen, Y., Na, X.-D., Chen, F., Wei, X., Li, Y.-Y., Liu, X., & Xin, W. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.09.017 · Cited by 83
Hiranita, T., Soto, P. L., Kohut, S. J., Kopajtic, T. A., Cao, J., Newman, A. H., Tanda, G., & Katz, J. L. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.185025 · Cited by 74
Self-citationDe, A., Krueger, J. M., & Simasko, S. M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02997-4 · Cited by 73
Youn, D., Wang, H., & Jeong, S. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21726 · Cited by 73
Variability of drug self-administration in rats
Panlilio, L. V., Katz, J. L., Pickens, R. W., & Schindler, C. W. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1366-x · Cited by 70
Self-citationMinocycline attenuates subjective rewarding effects of dextroamphetamine in humans
Sofuoglu, M., Mooney, M. E., Kosten, T. R., Waters, A. J., & Hashimoto, K. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2014-5 · Cited by 70
Liu, L., Coller, J. K., Watkins, L. R., Somogyi, A. A., & Hutchinson, M. R. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.016 · Cited by 66
Self-citationWang, Q., Zhou, H., Gao, H., Chen, S., Chu, C., Wilson, B. C., & Hong, J. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-32 · Cited by 65
Inhibition of TLR-4/MD-2 signaling by RP105/MD-1
Divanovic, S., Trompette, A., Atabani, S. F., Madan, R., Golenbock, D. T., Visintin, A., Finberg, R. W., Tarakhovsky, A., Vogel, S. N., Belkaid, Y., et al. (2005) · Journal of Endotoxin Research · doi:10.1179/096805105x67300 · Cited by 63
The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice
Fujita, Y., Kunitachi, S., Iyo, M., & Hashimoto, K. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.01.005 · Cited by 57
Pregnane X Receptor: Promiscuous regulator of detoxification pathways
Matic, M., Mahns, A., Tsoli, M., Corradin, A. P., Polly, P., & Robertson, G. R. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.08.017 · Cited by 56
Dunwiddie, T. V., Perez‐Reyes, E., Rice, K. C., & Palmer, M. R. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90027-6 · Cited by 22
Self-citationPTI-609: A Novel Analgesic that Binds Filamin A to Control Opioid Signaling
Burns, L. H., & Wang, H.-Y. (2010) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488910793362386 · Cited by 22
Cited by
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
Brown, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4675 · Cited by 359
Neurogenic inflammation and its role in migraine
Ramachandran, R. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0676-y · Cited by 310
The role of opioid receptors in immune system function
Eisenstein, T. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02904 · Cited by 286
Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse
Lacagnina, M. J., Rivera, P. D., & Bilbo, S. D. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.121 · Cited by 271
“An explanation for this effect may partly derive from alterations in dopaminergic transmission; similar to the result obtained using ibudilast, (+)-naloxone suppresses morphine-induced dopamine release into the NAc as measured by in vivo microdialysis (Hutchinson et al, 2012).”
BackgroundMethodResultInfluentialLee, K., Vuong, H. E., Nusbaum, D. J., Hsiao, E. Y., Evans, C. J., & Taylor, A. M. W. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0211-9 · Cited by 172
Metadata
- Authors
- Hutchinson, M. R., Northcutt, A. L., Hiranita, T., Wang, X., Lewis, S. S., Thomas, J., van Steeg, K., Kopajtic, T. A., Loram, L. C., Sfregola, C., Galer, E., Miles, N. E., Bland, S. T., Amat, J., Rozeske, R. R., Maslanik, T., Chapman, T. R., Strand, K. A., Fleshner, M., Bachtell, R. K., Somogyi, A. A., Yin, H., Katz, J. L., Rice, K. C., Maier, S. F., & Watkins, L. R.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2012-08-15
- Volume
- 32
- Issue
- 33
- Pages
- 11187-11200
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1975744086
- Cited by
- 346
- References
- 61
- FWCI
- 8.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.